4.5 Article

A genome-wide scan for common variants affecting the rate of age-related cognitive decline

期刊

NEUROBIOLOGY OF AGING
卷 33, 期 5, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2011.09.033

关键词

Cognitive decline; Genome-wide association study; Alzheimer's disease; Genetic risk score

资金

  1. National Institutes of Health [R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, R01 AG11101, 1P30 AG010129, K01 AG030514]
  2. Illinois Department of Public Health
  3. Beth Israel Deaconess Medical Center
  4. Harvard/MIT Health Sciences and Technology
  5. Pfizer Inc.
  6. Merck Co.
  7. NIA [R01 AG034504, K01AG024079, P50 AG23173]
  8. Johnnie B Byrd Institute
  9. Kronos Life Sciences Laboratories, the National Institute on Aging (Arizona Alzheimer's Disease Center) [P30 AG19610, R01 AG023193]
  10. Kronos Life Sciences Laboratories, the National Institute on Aging (Mayo Clinic Alzheimer's Disease Center) [P50 AG16574]
  11. National Alzheimer's Coordinating Center [U01 AG016976]
  12. state of Arizona
  13. NIH Neuroscience Blueprint [U24NS051872]
  14. ENDGAME Consortium [U01HL084744]
  15. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  16. National Institute of Biomedical Imaging and Bioengineering
  17. Dana Foundation

向作者/读者索取更多资源

Age-related cognitive decline is likely promoted by accumulated brain injury due to chronic conditions of aging, including neurodegenerative and vascular disease. Because common neuronal mechanisms may mediate the adaptation to diverse cerebral insults, we hypothesized that susceptibility for age-related cognitive decline may be due in part to a shared genetic network. We have therefore performed a genome-wide association study using a quantitative measure of global cognitive decline slope, based on repeated measures of 17 cognitive tests in 749 subjects from the Religious Orders Study. Top results were evaluated in 3 independent replication cohorts, consisting of 2279 additional subjects with repeated cognitive testing. As expected, we find that the Alzheimer's disease (AD) susceptibility locus, APOE, is strongly associated with rate of cognitive decline (P-DISC = 5.6 x 10(-9); P-JOINT = 3.7 x 10(-27)). We additionally discover a variant, rs10808746, which shows consistent effects in the replication cohorts and modestly improved evidence of association in the joint analysis (P-DISC = 6.7 x 10(-5); P-REP = 9.4 x 10(-3); P-JOINT = 2.3 x 10(-5)). This variant influences the expression of 2 adjacent genes, PDE7A and MTFR1, which are potential regulators of inflammation and oxidative injury, respectively. Using aggregate measures of genetic risk, we find that known susceptibility loci for cardiovascular disease, type 2 diabetes, and inflammatory diseases are not significantly associated with cognitive decline in our cohort. Our results suggest that intermediate phenotypes, when coupled with larger sample sizes, may be a useful tool to dissect susceptibility loci for age-related cognitive decline and uncover shared molecular pathways with a role in neuronal injury. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据